Stefano Rensi

Stefano Rensi is the Director of Artificial Intelligence at GSK (GlaxoSmithKline), where he focuses on integrating AI and machine learning into drug discovery processes. He has a strong academic background, having studied at Stanford University, which adds to his expertise in bioengineering and AI applications in pharmaceuticals.

Professional Background

• Current Role: Director of AI/ML Engineering at GSK, leading initiatives to enhance drug discovery through advanced technologies.
• Previous Experience: Rensi has held various roles in the intersection of bioengineering and artificial intelligence, contributing to research and development in these fields.

Contributions and Interests

Rensi is known for his enthusiasm for leveraging AI in medicinal chemistry, particularly in virtual screening and drug design. His work involves exploring innovative methods to streamline the drug discovery process, making it more efficient and effective.

Online Presence

He maintains an active profile on LinkedIn, where he shares insights related to his work in AI and drug discovery, and engages with a professional network of over 500 connections.12 Additionally, he is active on Twitter, where he discusses topics related to bioengineering and AI.3

Overall, Stefano Rensi's role at GSK positions him at the forefront of integrating cutting-edge technology into healthcare solutions.